Distributor IMCD has formed a new business group called Industrial Solutions, which will absorb the previous Synthesis group and areas of the other industries it serves. This has been done in response to such global trends as growing demand for products in applications like high-temperature, electronics and batteries, and sustainability, notably in recycling and water treatment.
Oleochemicals firm Oleon has begun construction of a $50 million production facility in Baytown, Texas. Due to be put into service end of 2023, this will produce esters and provide blending services to support the firm’s growing oil and gas business, while bringing it closer to customers in the North America, according to CEO Moussa Naciri.
Bryan Moran, global skin care technical manager at Lubrizol Life Science Beauty, discusses how formulators can address a key trend in sun care
In the 1970s and 1980s, no lifeguard would hit the beach without a thick white coating of zinc oxide sunblock on their nose. It was effective but also unattractive and uncomfortable.
A little flexibility in approach will improve consistency and enable pharma partners to perform to their optimum level. Ahead of her presentation on ‘How to Build a ‘Framework for Managing Your Outsourcing Partner’ at CPhI North America, we spoke with Stephanie Gaulding, executive director of regulatory compliance at Pharmatech Associates
At its Capital Markets Day, Evonik announced that it is embarking on the next phase of its strategic transformation. During this, said board chairman Christian Kullmann, the company will be “executing targeted and massive investments in green growth and making sustainability our central innovation driver”.
Stepan, the world’s largest dedicated producer of surfactants, has launched its Partners for Sustainable Supply (PaSS) programme on its sustainable procurement. This focuses on selecting goods and services suppliers to align environmental, social and governance (ESG) performance management and to ensure the use of responsibly sourced goods and services.
Miami-based HIG Capital alternative investment firm HIG Capital has agreed to sell Valtris Specialty Chemicals to an affiliate of funds managed by SK Capital Partners. The transaction is expected to close in Q3, subject to customary closing conditions. Terms were not disclosed.
Valtris is located in Independence, Ohio, and operates nine manufacturing facilities worldwide. It makes speciality polymer additives to impart flexibility, stability processability and flame retardance, plus speciality chemicals for a wide range of end markets.
